Emily Gruber
Impact in
-
- Acute Myeloid Leukemia Research
-
- CAR-T cell therapy research
Papers in
-
- Acute Myeloid Leukemia Research 4
- Multiple Myeloma Research and Treatments 2
-
- Protein Degradation and Inhibitors 4
- Histone Deacetylase Inhibitors Research 4
- Epigenetics and DNA Methylation 2
- Co-authors
- Lev M. Kats (7 shared papers)Ricky W. Johnstone (5 shared papers)Stephin J. Vervoort (3 shared papers)Izabela Todorovski (2 shared papers)Simon J. Hogg (3 shared papers)Jake Shortt (2 shared papers)Kevin Sek (1 shared paper)Phillip Kevin Darcy (1 shared paper)
- Journals
- Analytical Chemistry (2 papers)Leukemia (2 papers)JAMA Network Open (1 paper)Molecular Therapy (1 paper)Cancer Discovery (1 paper)
- Partner nations
- AustraliaUnited StatesNorway
In The Last Decade
Emily Gruber
19 papers receiving 340 citations
Peers
Comparison fields: 5 of 58
- Hematology 71
- Oncology 105
- Immunology 73
- Cancer Research 41
- Molecular Biology 170
Countries citing papers authored by Emily Gruber
This map shows the geographic impact of Emily Gruber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Gruber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Gruber more than expected).
Fields of papers citing papers by Emily Gruber
This network shows the impact of papers produced by Emily Gruber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Gruber. The network helps show where Emily Gruber may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Gruber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 92 | |
| 2 | 2021 | 61 | |
| 3 | 2020 | 26 | |
| 4 | 2020 | 25 | |
| 5 | 2022 | 25 | |
| 6 | 2022 | 21 | |
| 7 | 2022 | 19 | |
| 8 | 2016 | 14 | |
| 9 | 2017 | 13 | |
| 10 | 2018 | 8 | |
| 11 | 2025 | 8 | |
| 12 | 2023 | 7 | |
| 13 | 2023 | 6 | |
| 14 | 2023 | 5 | |
| 15 | 2024 | 5 | |
| 16 | 2024 | 3 | |
| 17 | 2025 | 3 | |
| 18 | 2023 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2025 | 0 |
About Emily Gruber
Emily Gruber is a scholar working on Hematology, Molecular Biology, Immunology, General Health Professions and Cancer Research, having authored 20 papers that have together received 343 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Acute Myeloid Leukemia Research (4 papers), Food Security and Health in Diverse Populations (2 papers), Epigenetics and DNA Methylation (2 papers), Multiple Myeloma Research and Treatments (2 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Hematology (71 citations), Oncology (105 citations), Immunology (73 citations), Cancer Research (41 citations) and Molecular Biology (170 citations). Emily Gruber has collaborated with scholars based in Australia, United States and Norway. Frequent co-authors include Lev M. Kats, Ricky W. Johnstone, Stephin J. Vervoort, Izabela Todorovski, Simon J. Hogg, Jake Shortt, Kevin Sek, Phillip Kevin Darcy, Kirsten L. Todd and Ian A. Parish. Their work appears in journals such as Analytical Chemistry, Leukemia, JAMA Network Open, Molecular Therapy and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.